- IOF International
- IOF Websites
- Member Societies
- - Algeria
- - Argentina
- - Australia
- - Austria
- - Belarus
- - Belgium
- - Bolivia
- - Bosnia and Herzegovina
- - Brazil
- - Bulgaria
- - Chile
- - Colombia
- - Congo, The Democratic Republic of the
- - Costa Rica
- - Croatia
- - Cuba
- - Cyprus
- - Czech Republic
- - Denmark
- - Dominican Republic
- - Ecuador
- - Estonia
- - France
- - Georgia
- - Germany
- - Greece
- - Guatemala
- - Hong Kong
- - Hungary
- - Iceland
- - India
- - Indonesia
- - Iran, Islamic Republic of
- - Iraq
- - Ireland
- - Israel
- - Italy
- - Jamaica
- - Japan
- - Jordan
- - Kenya
- - Korea, Republic of
- - Latvia
- - Lebanon
- - Lithuania
- - Luxembourg
- - Macedonia, Republic of
- - Mexico
- - Netherlands
- - New Zealand
- - Pakistan
- - Panama
- - Peru
- - Philippines
- - Poland
- - Portugal
- - Puerto Rico
- - Romania
- - Russian Federation
- - Saudi Arabia
- - Singapore
- - Slovakia
- - Slovenia
- - South Africa
- - Spain
- - Sri Lanka
- - Sweden
- - Switzerland
- - Syrian Arab Republic
- - Chinese Taipei
- - Thailand
- - Tunisia
- - Turkey
- - Ukraine
- - United Arab Emirates
- - United Kingdom
- - United States
- - Uruguay
- - Uzbekistan
- - Venezuela
- - Viet Nam
- - Serbia
- Sign In
- Sign Up
- Members Area
This page features osteoporosis guidelines from around the Asia-Pacific region. The International Osteoporosis Foundation (IOF) does not officially endorse national or regional guidelines. This is because osteoporosis prevalence and aspects of the prevention, diagnosis and treatment of fractures are country or region-specific. There may be multiple guidelines from any one country or region.
Access our list of guideline references. Where available, a link to the full text of a guideline is provided.
If your country or region has issued osteoporosis guidelines which are not included here, or if updated guidelines are available, please contact us.
Asia-Pacific
| Country or Region | Title of Guideline | Date | AGREE Appraised |
|---|---|---|---|
| Australia | Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. (ref. 44) | 2010 | No |
| China | Guidelines for osteoporosis diagnosis, Osteoporosis Committee of Chinese Gerontology Society (ref. 27) | 1999 | No |
| China | Guidelines for primary osteoporosis diagnosis and management, Osteoporosis and Bone Mineral Society of the Chinese Medical Association (ref. 28) | 2007 | No |
| China | Guidelines for osteoporosis fracture management, Orthopedic Society of Chinese Medical Association (ref. 29) |
2008 | No |
| Japan | Japanese guidelines for the prevention and treatment of osteoporosis. (ref 46) | 2011 | No |
| Japan | Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (ref 47) | 2004 | No |
| Malaysia | Clinical Practice Guidelines on Management of Osteoporosis 2012 (ref 25) | 2012 | No |
| Philippines | TBC | ||
| Singapore | Osteoporosis Clinical Practice Guidelines (ref. 41) | 2009 | No |
| Sri Lanka | Guidelines for the Management of Osteoporosis | 2002 | No |
| Taiwan | Taiwanese Guidelines for the Prevention and Treatment of Osteoporosis (ref. 49) | Updated 2012 |
No |
| Thailand | Treatment Guidelines for Postmenopausal Osteoporosis by TOPF & Dept of Public Health | ||
| Asian Regional | Guidelines for diagnosing, prevention and treatment of osteoporosis in Asia - Consensus meeting (ref. 42) | 2004 | No |
